2018 Medical Records Pharmaceutical Companies 
Pharmaceutical Technology
OCTOBER 25, 2022
But if healthcare providers cannot match these profiles to determine the patient's identity and link it to their medical records, it can delay treatments. With the rush to ensure GDPR compliance in 2018, Jackson says that many companies purchased off-the-shelf software to meet requirements. That's why we're different.”.
The Happy PharmD
AUGUST 4, 2023
It looked like the logo of a well-known pharmaceutical company. I looked up their phone number and decided to call the company on the phone. Eventually, I spoke to a woman in the company’s medical library department. He told me about the medication, as well as stated what was written on the vials.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 6, 2022
In 2018, the 100,000 Genomes Project completed its collection of data from 100,000 participants and the study of that collected information is still on-going. A few decades ago, gathering genetic data on the scale of the 100,000 Genomes Project would have been unthinkable – it was only in 2003 that the entire human genome was mapped.
Hospital Pharmacy Europe
JANUARY 18, 2023
A patient access scheme or commercial arrangement associated with the NICE guidance is a way for pharmaceutical companies to lower the acquisition cost to the NHS to improve its cost-effectiveness, so enabling patients to gain access to high-cost medicine treatments. TA534, August 2018. References. www.nice.org.uk/guidance/ta534
Expert insights. Personalized for you.
52 
Let's personalize your content